Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Seasonal Incidence of Symptomatic Influenza in the United States.

Tokars JI, Olsen SJ, Reed C.

Clin Infect Dis. 2018 May 2;66(10):1511-1518. doi: 10.1093/cid/cix1060.

PMID:
29206909
2.

Phase 1 Safety and Immunogenicity Study of a Quadrivalent Seasonal Flu Vaccine Comprising Recombinant Hemagglutinin-Flagellin Fusion Proteins.

Tussey L, Strout C, Davis M, Johnson C, Lucksinger G, Umlauf S, Song L, Liu G, Abraham K, White CJ.

Open Forum Infect Dis. 2016 Jan 29;3(1):ofw015. doi: 10.1093/ofid/ofw015. eCollection 2016 Jan.

3.

Recombinant Hemagglutinin and Virus-Like Particle Vaccines for H7N9 Influenza Virus.

Li X, Pushko P, Tretyakova I.

J Vaccines Vaccin. 2015 Jun;6(3). pii: 287. Epub 2015 Jun 30.

4.

Safety, efficacy, and immunogenicity of Flublok in the prevention of seasonal influenza in adults.

Cox MM, Izikson R, Post P, Dunkle L.

Ther Adv Vaccines. 2015 Jul;3(4):97-108. doi: 10.1177/2051013615595595. Review.

5.

Development and applications of single-cycle infectious influenza A virus (sciIAV).

Nogales A, Baker SF, Domm W, Martínez-Sobrido L.

Virus Res. 2016 May 2;216:26-40. doi: 10.1016/j.virusres.2015.07.013. Epub 2015 Jul 26. Review.

6.
7.

Recombinant H7 hemagglutinin forms subviral particles that protect mice and ferrets from challenge with H7N9 influenza virus.

Pushko P, Pujanauski LM, Sun X, Pearce M, Hidajat R, Kort T, Schwartzman LM, Tretyakova I, Chunqing L, Taubenberger JK, Tumpey TM.

Vaccine. 2015 Sep 11;33(38):4975-82. doi: 10.1016/j.vaccine.2015.07.026. Epub 2015 Jul 21.

8.

Transgene expression in Penaeus monodon cells: evaluation of recombinant baculoviral vectors with shrimp specific hybrid promoters.

Puthumana J, Philip R, Bright Singh IS.

Cytotechnology. 2016 Aug;68(4):1147-59. doi: 10.1007/s10616-015-9872-y. Epub 2015 May 17.

9.

Designs of two randomized, community-based trials to assess the impact of influenza immunization during pregnancy on respiratory illness among pregnant women and their infants and reproductive outcomes in rural Nepal.

Tielsch JM, Steinhoff M, Katz J, Englund JA, Kuypers J, Khatry SK, Shrestha L, LeClerq SC.

BMC Pregnancy Childbirth. 2015 Feb 20;15:40. doi: 10.1186/s12884-015-0470-y.

10.

Lessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteins.

Zhang X, Xin L, Li S, Fang M, Zhang J, Xia N, Zhao Q.

Hum Vaccin Immunother. 2015;11(5):1277-92. doi: 10.1080/21645515.2015.1016675. Review.

11.

RNA virus reverse genetics and vaccine design.

Stobart CC, Moore ML.

Viruses. 2014 Jun 25;6(7):2531-50. doi: 10.3390/v6072531. Review.

12.

Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis.

Tricco AC, Chit A, Soobiah C, Hallett D, Meier G, Chen MH, Tashkandi M, Bauch CT, Loeb M.

BMC Med. 2013 Jun 25;11:153. doi: 10.1186/1741-7015-11-153. Review.

13.

Safety and immune responses in children after concurrent or sequential 2009 H1N1 and 2009-2010 seasonal trivalent influenza vaccinations.

Frey SE, Bernstein DI, Gerber MA, Keyserling HL, Munoz FM, Winokur PL, Turley CB, Rupp RE, Hill H, Wolff M, Noah DL, Ross AC, Cress G, Belshe RB.

J Infect Dis. 2012 Sep 15;206(6):828-37. doi: 10.1093/infdis/jis445. Epub 2012 Jul 16.

14.

Incidence of influenza in healthy adults and healthcare workers: a systematic review and meta-analysis.

Kuster SP, Shah PS, Coleman BL, Lam PP, Tong A, Wormsbecker A, McGeer A.

PLoS One. 2011;6(10):e26239. doi: 10.1371/journal.pone.0026239. Epub 2011 Oct 18. Review.

15.

Subcutaneous immunization with baculovirus surface-displayed hemagglutinin of pandemic H1N1 Influenza A virus induces protective immunity in mice.

Prabakaran M, Meng T, He F, Yunrui T, Qiang J, Lin RT, Kwang J.

Clin Vaccine Immunol. 2011 Sep;18(9):1582-5. doi: 10.1128/CVI.05114-11. Epub 2011 Jul 13.

16.

Immunogenicity and efficacy of flagellin-fused vaccine candidates targeting 2009 pandemic H1N1 influenza in mice.

Liu G, Tarbet B, Song L, Reiserova L, Weaver B, Chen Y, Li H, Hou F, Liu X, Parent J, Umlauf S, Shaw A, Tussey L.

PLoS One. 2011;6(6):e20928. doi: 10.1371/journal.pone.0020928. Epub 2011 Jun 7.

17.

Enhanced immunogenicity, mortality protection, and reduced viral brain invasion by alum adjuvant with an H5N1 split-virion vaccine in the ferret.

Layton RC, Gigliotti A, Armijo P, Myers L, Knight J, Donart N, Pyles J, Vaughan S, Plourde J, Fomukong N, Harrod KS, Gao P, Koster F.

PLoS One. 2011;6(6):e20641. doi: 10.1371/journal.pone.0020641. Epub 2011 Jun 7.

18.

New approaches to confronting an imminent influenza pandemic.

Fedson DS, Dunnill P.

Perm J. 2007 Summer;11(3):63-9.

PMID:
21461116
Free PMC Article
19.

Enhanced immunogenicity of stabilized trimeric soluble influenza hemagglutinin.

Weldon WC, Wang BZ, Martin MP, Koutsonanos DG, Skountzou I, Compans RW.

PLoS One. 2010 Sep 1;5(9). pii: e12466. doi: 10.1371/journal.pone.0012466.

20.

Bench-to-bedside review: vaccine protection strategies during pandemic flu outbreaks.

Chua JV, Chen WH.

Crit Care. 2010;14(2):218. doi: 10.1186/cc8891. Epub 2010 Apr 16. Review.

Supplemental Content

Support Center